Wren Therapeutics

Cambridge Centre for Protein Misfolding Diseases, University of Cambridge, Lund University

Broad drug discovery platform solving the technical hurdles to assaying, analyzing, and targeting fleeting neurotoxic oligomers, enabling the central molecular cause of neurodegeneration to be addressed directly.

$40.3M

Network-centric paradigm for drug discovery allows us to see the oligomer protein production pathway and discover small molecules that can block their generation with precision.